Company Directory / hospital & health care
PrivateFor profithospital & health careOxford, United Kingdom
Ultromics
Ultromics clinicians and engineers working together to set new standards for world-class cardiovascular diagnostic tools.
- Founded
- 2017 9 years ago
- Staff
- 51-100 band, as listed
- Followers
- - on LinkedIn
- Funding
- $59M as listed, currency not stated
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed
Age
9 years old.
Reach
Website ranked #4,107,615 in the world for traffic, about 3k visits a month.
What it does
Artificial Intelligence (AI)Computer VisionHealth CareHealth DiagnosticsMedicalSoftware
Funding, as listed
$59M currency not stated
- Rounds5
- LatestSeries b, Aug 2021
- Investors13, 2 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Ultromics, field by field. Contact details are held but never shown.
The company
- Name
- Ultromics
- Type
- For profit
- Status
- Private
- Founded
- 2017
- Founders
- Paul Leeson, Ross Upton
- Industry
- hospital & health care
- Categories
- Artificial Intelligence (AI), Computer Vision, Health Care, Health Diagnostics, Medical, Software
Where
- City
- Oxford
- Country
- United Kingdom
- Markets
- Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 51-100
- Web traffic rank
- #4,107,615
- Monthly web visits
- 2,533
Funding, as listed
- Total
- 58,824,943 (currency not stated)
- Rounds
- 5
- Latest round
- Series b
- Latest round date
- Aug 2021
- Investors
- 13
- Lead investors
- 2
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Ultromics may be growing as evidenced by the FDA clearance for its EchoGo product, which is a significant regulatory milestone that can lead to increased market adoption and sales. Additionally, Ultromics is recognized as a leading health technology company at the forefront of detection, indicating a strong market position and potential for further expansion. The global cardiac AI monitoring and diagnostics market, where Ultromics operates, is also experiencing growth, with a projected market value increase, which may positively impact Ultromics' business.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
hospital & health care in United Kingdom.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 372,993 companies in United Kingdom and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.